MAP2K1 and respiratory tract infectious disorder: One potential therapeutic strategy to combat respiratory infections and inflammation has been developed from understanding the functional roles of mammalian serine threonine protein kinases Map2k1 (MEK1) and Map2k2 (MEK2).